165 related articles for article (PubMed ID: 9372040)
21. Photochemical inactivation of viruses and bacteriophage in plasma and plasma fractions.
Morel P; Lin L; Wiesehahn G; Corash L
Blood Cells; 1992; 18(1):27-41; Discussion 41-2. PubMed ID: 1617190
[TBL] [Abstract][Full Text] [Related]
22. [Virus safety of fresh frozen plasma].
Sugg U
Beitr Infusionsther; 1989; 24():56-9. PubMed ID: 2481549
[TBL] [Abstract][Full Text] [Related]
23. Use of 8-methoxypsoralen and long wavelength ultraviolet radiation for decontamination of platelet concentrates.
Corash L; Lin L; Wiesehahn G
Blood Cells; 1992; 18(1):57-73; discussion 74. PubMed ID: 1617193
[TBL] [Abstract][Full Text] [Related]
24. [Transfusions of blood and blood products and virus infections].
Wróblewska M; Piotrowska E; ĺuczak M
Postepy Hig Med Dosw; 2002; 56(2):221-40. PubMed ID: 12107964
[TBL] [Abstract][Full Text] [Related]
25. Safety of coagulation factor concentrates.
Teitel JM
Haemophilia; 1998 Jul; 4(4):393-401. PubMed ID: 9873760
[TBL] [Abstract][Full Text] [Related]
26. Inactivation of viruses found with cellular components.
Horowitz B; Valinsky J
Biotechnology; 1991; 19():431-50. PubMed ID: 1786477
[No Abstract] [Full Text] [Related]
27. The development of virus-free labile blood derivatives--a review.
Prince AM; Horowitz B; Horowitz MS; Zang E
Eur J Epidemiol; 1987 Jun; 3(2):103-18. PubMed ID: 3301391
[TBL] [Abstract][Full Text] [Related]
28. [Viral attenuation of labile blood products].
Folléa G; Hervé P; Andreu G; Bidet JM; Boudard D; Dazey B; Noël L; Piquet Y
Transfus Clin Biol; 1996; 3(2):113-23. PubMed ID: 8963430
[TBL] [Abstract][Full Text] [Related]
29. Viral safety of human plasma-derived medicinal products: impact of regulation requirements.
Velthove KJ; Over J; Abbink K; Janssen MP
Transfus Med Rev; 2013 Jul; 27(3):179-83. PubMed ID: 23886505
[TBL] [Abstract][Full Text] [Related]
30. Emerging issues in blood safety.
Chamberland M; Khabbaz RF
Infect Dis Clin North Am; 1998 Mar; 12(1):217-29. PubMed ID: 9494840
[TBL] [Abstract][Full Text] [Related]
31. Reflections on current status of blood transfusion transplant viral safety in UK/Europe and on novel strategies for enhancing donors/recipients healthcare in promising era of advanced cell therapy/regenerative medicine.
Seghatchian J
Transfus Apher Sci; 2019 Aug; 58(4):532-537. PubMed ID: 31248735
[TBL] [Abstract][Full Text] [Related]
32. Efforts in minimizing risk of viral transmission through viral inactivation.
Horowitz B; Ben-Hur E
Ann Med; 2000 Oct; 32(7):475-84. PubMed ID: 11087168
[TBL] [Abstract][Full Text] [Related]
33. Approaches to the reduction of viral infectivity in cellular blood components and single donor plasma.
Wagner SJ; Friedman LI; Dodd RY
Transfus Med Rev; 1991 Jan; 5(1):18-32. PubMed ID: 1802274
[No Abstract] [Full Text] [Related]
34. Pathogen inactivation: emerging indications.
Kleinman S
Curr Opin Hematol; 2015 Nov; 22(6):547-53. PubMed ID: 26390164
[TBL] [Abstract][Full Text] [Related]
35. Risks and side effects of therapy with plasma and plasma fractions.
MacLennan S; Barbara JA
Best Pract Res Clin Haematol; 2006; 19(1):169-89. PubMed ID: 16377549
[TBL] [Abstract][Full Text] [Related]
36. Progress in improving the pathogen safety of red cell concentrates.
Chapman J
Vox Sang; 2000; 78 Suppl 2():203-4. PubMed ID: 10938953
[TBL] [Abstract][Full Text] [Related]
37. Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings.
Owusu-Ofori S; Temple J; Sarkodie F; Anokwa M; Candotti D; Allain JP
Transfusion; 2005 Feb; 45(2):133-40. PubMed ID: 15660820
[TBL] [Abstract][Full Text] [Related]
38. Reducing the risk of infection from plasma products: specific preventative strategies.
Burnouf T; Radosevich M
Blood Rev; 2000 Jun; 14(2):94-110. PubMed ID: 11012252
[TBL] [Abstract][Full Text] [Related]
39. [Blood-transmitted viral infections among haemophiliacs in Tunisia].
Langar H; Triki H; Gouider E; Bahri O; Djebbi A; Sadraoui A; Hafsia A; Hafsia R
Transfus Clin Biol; 2005 Oct; 12(4):301-5. PubMed ID: 16099190
[TBL] [Abstract][Full Text] [Related]
40. Tissue donation and virus safety: more nucleic acid amplification testing is needed.
Pruss A; Caspari G; Krüger DH; Blümel J; Nübling CM; Gürtler L; Gerlich WH
Transpl Infect Dis; 2010 Oct; 12(5):375-86. PubMed ID: 20412535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
